FGF19, FGF21 and an FGFR1/β-Klotho-activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia

Despite their different physiologic functions as hormonal regulators of fed and fasted metabolism, pharmacologic administration of FGF19 and FGF21 similarly cause increases in energy expenditure, weight loss and enhanced insulin sensitivity in obese animals. Here, in genetic loss-of-function studies...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Metab
Main Authors: Lan, Tian, Morgan, Donald A., Rahmouni, Kamal, Sonoda, Junichiro, Fu, Xiaorong, Burgess, Shawn C., Holland, William L., Kliewer, Steven A., Mangelsdorf, David J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679468/
https://ncbi.nlm.nih.gov/pubmed/28988823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2017.09.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados